The Scientific Research Team at ImmunoACT focuses on advancing the development of innovative cell and gene therapies, specifically targeting blood cancers. Comprising scientists at various levels, the team conducts cutting-edge research, designs experimental protocols, and analyzes data to optimize CAR-T cell therapy solutions, ultimately aiming to make these therapies accessible and affordable for patients in India.
View all